Savvy Psychopharmacology

Managing psychotropic-induced hyperhidrosis

Author and Disclosure Information

 

References

However, anticholinergic medications may still have a role in treating psychotropic-induced hyperhidrosis. Benztropine3,7,8 and cyproheptadine2,3,9 may be effective options, though their role in treating psychotropic-induced hyperhidrosis should be limited and reserved for patients who have another compelling indication for these medications (eg, extrapyramidal symptoms) or when other treatment options are ineffective or intolerable.

Avoiding anticholinergic medications can also be justified based on the proposed mechanism of psychotropic-induced hyperhidrosis as an extension of the medication’s toxic effects. Conceptualizing psychotropic-induced hyperhidrosis as similar to the diaphoresis and hyperthermia observed in neuroleptic malignant syndrome and serotonin syndrome offers a clearer target for treatment. Though the specifics of the mechanisms remain unknown,2 many medications that cause hyperhidrosis do so by increasing sweat gland secretions, either directly by increasing cholinergic activity or indirectly via increased sympathetic transmission.

Considering this pathophysiology, another target for psychotropic-induced hyperhidrosis may be altered and/or excessive catecholamine activity. The use of medications such as clonidine,3-6 propranolol,4-6 or terazosin2,3,10 should be considered given their beneficial effects on the activation of the sympathetic nervous system, although clonidine also possesses anticholinergic activity. The calcium channel blocker diltiazem can improve hyperhidrosis symptoms by interfering with the calcium signaling necessary for normal sweat gland function.4,5 Comorbid cardiovascular diseases and tachycardia, an adverse effect of many psychotropic medications, may also be managed with these treatment options. Some research suggests using benzodiazepines to treat psychotropic-induced hyperhidrosis.4-6 As is the case for anticholinergic medications, the use of benzodiazepines would require another compelling indication for long-term use.

Table 23,4,6-8,10 provides recommended dosing and caveats for the use of these medications and other potentially appropriate medications.

Oral medications for treating psychotropic-induced hyperhidrosis

Research of investigational treatments for generalized hyperhidrosis is ongoing. It is possible some of these medications may have a future role in the treatment of psychotropic-induced hyperhidrosis, with improved efficacy and better tolerability.

Continue to: CASE CONTINUED

Recommended Reading

LSD use triples among young adults with depression
MDedge Psychiatry
Fathers’ postpartum depression linked to children’s adversity
MDedge Psychiatry
Tricyclics may raise fracture risk in type 2 diabetes
MDedge Psychiatry
Specialized care may curb suicide risk in veterans with disabilities
MDedge Psychiatry
Postmenopausal stress linked to mood, cognitive symptoms
MDedge Psychiatry
Pandemic-era telehealth led to fewer therapy disruptions
MDedge Psychiatry
Lag in antidepressant treatment response explained?
MDedge Psychiatry
Air pollution tied to postpartum depression
MDedge Psychiatry
Psychedelic therapy tied to reduced depression, anxiety
MDedge Psychiatry
Ketamine no better for depression than placebo?
MDedge Psychiatry